Skip to Content
Merck
  • Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives.

Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives.

Bioorganic & medicinal chemistry letters (2012-01-11)
Halis T Balaydın, Murat Sentürk, Abdullah Menzek
ABSTRACT

The Naturally occurring novel cyclohexanonyl bromophenol 2(R)-2-(2,3,6-tribromo-4,5-dihydroxybenzyl)cyclohexanone (4) was synthesized as a racemic compound. Cyclohexylphenyl methane derivatives (10-17) with Br, OMe, CO, and OH were also obtained. Inhibition of four human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I, II, IV, and VI, with compounds 2-4, 8, and 10-26 was investigated. These compounds were found to be promising carbonic anhydrase inhibitors and some of them showed interesting inhibitory activity. Some of the compounds investigated here showed effective hCA inhibitory activity, and might be used as leads for generating novel carbonic anhydrase inhibitors which are valuable drug candidates for the treatment of glaucoma, epilepsy, gastric and duodenal ulcers, neurological disorders, and osteoporosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,2-Dimethoxybenzene, ReagentPlus®, 99%
Sigma-Aldrich
Benzenesulfonamide, ≥98%
Sigma-Aldrich
2-Methylcyclohexanol, mixture of cis and trans, 99%
Sigma-Aldrich
1,2-Dimethoxybenzene, ≥99%, FG
Sigma-Aldrich
2-Methylcyclohexanone, 99%